@FierceBiotech: Pfizer to lop off Asian research unit amid major R&D downsizing. Story | Follow @FierceBiotech
@RyanMFierce: Troubled biotech Tranzyme mulls potential sale after R&D face plants. More | Follow @RyanMFierce
> Pharma companies are changing their approach to how they conduct drug trials. Story
> Pergamum AB and Cadila Pharmaceuticals have formed a partnership to develop therapies to treat infections. Press release
> Infinity Pharmaceuticals ($INFI) saw a 6-fold rise in market share, from $5.98 a share on its lowest day of 2012, to $35.02 at yesterday's close. Story
> Biotechs are embracing RNA therapeutics. Story
Pharma News
@FiercePharma: Turns out, Vivus' slow launch of Qsymia may be best plan. News | Follow @FiercePharma
@EricPFierce: Sun tells Taro shareholders to forget it, cancels $685 million offer for Israeli generic drug player. Report | Follow @EricPFierce
@AlisonBFierce: Evidence of a link between GSK's Pandemrix and a spike in narcolepsy cases is putting AS03 under intense scrutiny. More | Follow @AlisonBFierce
> Court spoons out good news for Merck investors. Report
> Pfizer cuts some more, closing R&D site in Singapore. Item
@FierceMedDev: Ultrasound elastography eyed as cancer Dx method. Report | Follow @FierceMedDev
@MarkHFierce: India is competing with the larger device companies by launching firms that make cheaper, quality alternatives. News | Follow @MarkHFierce
@DamianFierce: LabCorp joins the list of diagnostics providers expecting Medicare cuts to take a bite out of 2013 revenue. Story | Follow @DamianFierce
> India's med device outfits beat multinationals on price. News
> Insulet ditches DexCom in diabetes collaboration. Article
And Finally... Who would have thought? A major investor picks hot takeover candidates in biotech--from his own firm's portfolio. Seriously. Story